Lyell Immunopharma shares owned by Geode Capital Management
Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Geode Capital Management
from 13F filings
Historical chart of Geode Capital Management investment in Lyell Immunopharma
Tip: Access up to 7 years of quarterly data
All positions including Lyell Immunopharma held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lyell Immunopharma by Geode Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $5.8M | 4.0M | 1.45 |
| 2024-03-31 | $9.0M | 4.0M | 2.23 |
| 2023-09-30 | $5.4M | 3.7M | 1.47 |
| 2023-06-30 | $11M | 3.4M | 3.18 |
| 2023-03-31 | $7.5M | 3.2M | 2.36 |
| 2022-12-31 | $11M | 3.1M | 3.47 |
| 2022-09-30 | $22M | 3.0M | 7.33 |
| 2022-06-30 | $12M | 1.9M | 6.52 |
| 2022-03-31 | $7.3M | 1.5M | 5.05 |
| 2021-12-31 | $4.3M | 559k | 7.74 |
| 2021-09-30 | $7.9M | 532k | 14.80 |
| 2021-06-30 | $2.8M | 174k | 16.24 |